These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 25736426)

  • 1. Overdiagnosis in mammography screening: a 45 year journey from shadowy idea to acknowledged reality.
    Barratt A
    BMJ; 2015 Mar; 350():h867. PubMed ID: 25736426
    [No Abstract]   [Full Text] [Related]  

  • 2. StatBite: Percent change in DCIS, invasive breast cancer, and mammography.
    J Natl Cancer Inst; 2011 Mar; 103(6):457. PubMed ID: 21393608
    [No Abstract]   [Full Text] [Related]  

  • 3. Variation in detection of ductal carcinoma in situ during screening mammography: a survey within the International Cancer Screening Network.
    Lynge E; Ponti A; James T; Májek O; von Euler-Chelpin M; Anttila A; Fitzpatrick P; Frigerio A; Kawai M; Scharpantgen A; Broeders M; Hofvind S; Vidal C; Ederra M; Salas D; Bulliard JL; Tomatis M; Kerlikowske K; Taplin S;
    Eur J Cancer; 2014 Jan; 50(1):185-92. PubMed ID: 24041876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends in detection of invasive cancer and ductal carcinoma in situ at biennial screening mammography in Spain: a retrospective cohort study.
    Román M; Rué M; Sala M; Ascunce N; Baré M; Baroja A; De la Vega M; Galcerán J; Natal C; Salas D; Sánchez-Jacob M; Zubizarreta R; Castells X;
    PLoS One; 2013; 8(12):e83121. PubMed ID: 24376649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persistent Untreated Screening-Detected Breast Cancer: An Argument Against Delaying Screening or Increasing the Interval Between Screenings.
    Arleo EK; Monticciolo DL; Monsees B; McGinty G; Sickles EA
    J Am Coll Radiol; 2017 Jul; 14(7):863-867. PubMed ID: 28457814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overcalling low-risk findings: grouped amorphous calcifications found at screening mammography associated with minimal cancer risk.
    Iwase M; Tsunoda H; Nakayama K; Morishita E; Hayashi N; Suzuki K; Yamauchi H
    Breast Cancer; 2017 Jul; 24(4):579-584. PubMed ID: 27873170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening for early breast cancer reduces invasive cancer, study finds.
    Mayor S
    BMJ; 2015 Dec; 351():h6576. PubMed ID: 26643040
    [No Abstract]   [Full Text] [Related]  

  • 8. Detection of ductal carcinoma in situ and subsequent interval cancers.
    Shieh Y; Eklund M; Esserman L
    BMJ; 2016 Feb; 352():i551. PubMed ID: 26834245
    [No Abstract]   [Full Text] [Related]  

  • 9. Breast cancer screening with tomosynthesis (3D mammography) with acquired or synthetic 2D mammography compared with 2D mammography alone (STORM-2): a population-based prospective study.
    Bernardi D; Macaskill P; Pellegrini M; Valentini M; Fantò C; Ostillio L; Tuttobene P; Luparia A; Houssami N
    Lancet Oncol; 2016 Aug; 17(8):1105-1113. PubMed ID: 27345635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DCIS and invasive interval breast cancer.
    Narod SA; Sopik V; Sun P
    Lancet Oncol; 2016 Mar; 17(3):e87-e88. PubMed ID: 26972859
    [No Abstract]   [Full Text] [Related]  

  • 11. DCIS and invasive interval breast cancer.
    Foucar E
    Lancet Oncol; 2016 Mar; 17(3):e87. PubMed ID: 26972860
    [No Abstract]   [Full Text] [Related]  

  • 12. Incidence of breast cancer and estimates of overdiagnosis after the initiation of a population-based mammography screening program.
    Coldman A; Phillips N
    CMAJ; 2013 Jul; 185(10):E492-8. PubMed ID: 23754101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening mammography for young women treated with supradiaphragmatic radiation for Hodgkin's lymphoma.
    Lee L; Pintilie M; Hodgson DC; Goss PE; Crump M
    Ann Oncol; 2008 Jan; 19(1):62-7. PubMed ID: 17878177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of DCIS and reduced invasive interval cancers.
    Evans A
    Lancet Oncol; 2016 Jan; 17(1):14-5. PubMed ID: 26655426
    [No Abstract]   [Full Text] [Related]  

  • 15. DCIS and invasive interval breast cancer - Author's reply.
    Duffy SW
    Lancet Oncol; 2016 Mar; 17(3):e88-e89. PubMed ID: 26972861
    [No Abstract]   [Full Text] [Related]  

  • 16. Ductal Carcinoma In Situ and Breast Cancer Overdiagnosis.
    Jatoi I
    J Clin Oncol; 2022 May; 40(14):1595. PubMed ID: 35245098
    [No Abstract]   [Full Text] [Related]  

  • 17. Mode of detection and secular time for ductal carcinoma in situ.
    Pisano ED
    J Natl Cancer Inst Monogr; 2010; 2010(41):142-4. PubMed ID: 20956819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimizing Mammography Screening Intervals.
    Yi M; Hunt KK
    JAMA; 2015 Oct; 314(15):1635-6. PubMed ID: 26501538
    [No Abstract]   [Full Text] [Related]  

  • 19. Screening mammography after autologous breast reconstruction is not beneficial.
    Barton MK
    CA Cancer J Clin; 2015; 65(1):3-4. PubMed ID: 25533748
    [No Abstract]   [Full Text] [Related]  

  • 20. [Audit system on quality of breast cancer diagnosis and treatment: results of quality indicators on screen-detected lesions in Italy, 2010].
    Ponti A; Mano MP; Tomatis M; Baiocchi D; Barca A; Berti R; Bisanti L; Casella D; Deandrea S; Delrio D; Donati G; Falcini F; Frammartino B; Frigerio A; Mantellini P; Naldoni C; Orzalesi L; Pagano G; Pietribiasi F; Ravaioli A; Sedda ML; Taffurelli M; Cataliotti L; Segnan N
    Epidemiol Prev; 2012; 36(6 Suppl 1):87-95. PubMed ID: 23293273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.